🔖
Cite This Article
AGRAWAL, S., GUPTA, N., GOEL, A. D. (2020). Evidence Based Treatment of SARS-CoV2: A Narrative Review. Turkish Thoracic Journal, Cilt: 21 - Sayı: 3, 221–222. https://ajindex.com/articles/417971
Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 3
Evidence Based Treatment of SARS-CoV2: A Narrative Review
- Journal
- Turkish Thoracic Journal
- Pages
- 221–222
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (3)
- Guan W, Ni Z, Hu Y, et al. clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020
- De Wit E, Van Doremalen N, Falzarano D, et al. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523-3. [Crossref] 3. Cao B, Wang Y, Wen D, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020
- Wang Z, Chen X, Lu Y, et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel Coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 2020;14:64-68. [Crossref] 5. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: Results of an openlabel non-randomized clinical trial. Int J Antimicrob Agents 2020. [Crossref] 6 Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. 2020. Available from: URL: https://spiral.imperial.ac.uk:8443/handle/10044/1/77482.